Equity-Accounted Investees and Joint Business - BioDarou P.J.S. Co. (Details) € in Millions |
Apr. 25, 2022
EUR (€)
|
|---|---|
| BioDarour P.J.S. Co. | |
| Equity-Accounted Investees and Joint Business | |
| Percentage of ownership in joint venture | 49.00% |
| Biotest AG | |
| Equity-Accounted Investees and Joint Business | |
| Percentage of interest acquired | 70.18% |
| Consideration | € 1,461 |
| X | ||||||||||
- Definition The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Total for all joint ventures [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|